10 hours ago

Strategy Buys $101M in Bitcoin After Last Week’s Sale

Saylor’s Strategy Thunders Back After Last Week’s Bitcoin Sale Rattles Crypto Sector, Acquires $101,000,000 Worth of BTC

The Daily Hodl

Key Point

Strategy purchased 1,550 BTC for $101 million. The purchase increased Strategy’s total holdings to 845,256 Bitcoin. The buy followed last week’s sale of 32 BTC worth $2.47 million. Saylor noted that Strategy also increased its U.S. dollar reserve by $100 million to $1.0 billion. Strategy’s stock is up more than 6% on Monday, but remains more than 10% down in the past five days.

Why it matters: Corporate treasury buying may support Bitcoin demand expectations when investors see repeated accumulation from a large public holder.

Market Sentiment

Cautiously Bullish, Flow-led, Volatile.

Reason: Strategy bought 1,550 BTC for $101 million, which supports Bitcoin demand sentiment while keeping the read measured.

Similar Past Cases

In April 2026, Strategy purchased 4,871 BTC for $330 million, but CoinDesk said the buying had a relatively small effect compared with broader market forces. (CoinDesk) Difference: The current purchase follows a rare prior sale, so investor attention may focus more on treasury policy consistency than on buy size alone.

Ripple Effect

Corporate treasury buying can support demand expectations when investors believe the buyer can keep funding purchases. If Strategy keeps adding BTC after the sale, then investors may view the sale as a funding tool rather than a retreat. If more sales follow, then the market may reassess the reliability of treasury buyers as a demand source.

Opportunities & Risks

Opportunities: If future announcements show renewed BTC purchases and stable dollar reserves, then adding exposure after confirmation can capture improved treasury-demand sentiment.

Risks: If Strategy announces another BTC sale to fund dividends, then reducing exposure can limit downside from weaker confidence in the accumulation strategy.

This content is an AI-generated summary/analysis for informational purposes only and does not constitute investment advice.